3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Leukemia, Myeloid, Acute
20
Lymphoma, Non-Hodgkin
19
Hodgkin Disease
18
Multiple Myeloma
17
Myelodysplastic Syndromes
16
Lymphoma
16
Graft vs Host Disease
16
Lymphoma, Mantle-Cell
15
Leukemia, Lymphocytic, Chronic, B-Cell
15
Leukemia
14
Sarcoma
11
Lymphoma, Large B-Cell, Diffuse
11
Lymphoma, Follicular
11
Glioblastoma
11
Tuberous Sclerosis
10
Lymphoma, B-Cell, Marginal Zone
10
Carcinoma, Renal Cell
10
Neoplasms
9
Hematologic Neoplasms
9
Gliosarcoma
9
Carcinoma, Hepatocellular
9
Breast Neoplasms
9
Brain Neoplasms
9
Waldenstrom Macroglobulinemia
8
Myeloproliferative Disorders
8
Melanoma
8
Burkitt Lymphoma
8
Recurrence
7
Neoplasm Metastasis
7
Interventions
Temozolomide
13
Filgrastim
8
Carboplatin
8
Radiotherapy
7
Magnetic Resonance Spectroscopy
7
Etoposide
7
Cisplatin
7
Cyclophosphamide
6
Bevacizumab
6
Vincristine
4
Thiotepa
4
Carmustine
4
sargramostim
3
Surveys and Questionnaires
3
Peripheral Blood Stem Cell Transplantation
3
Methotrexate
3
Lapatinib
3
Irinotecan
3
Azacitidine
3
veliparib
2
alovudine
2
aldesleukin
2
Tamoxifen
2
Radiotherapy, Conformal
2
Radiation
2
Paclitaxel
2
Mental Status and Dementia Tests
2
Imatinib Mesylate
2
Granulocyte-Macrophage Colony-Stimulating Factor
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Ependymoma
×
Sirolimus
×
Clear all
NCT01331135
2020-05-29
Aflac ST0901
Emory University
Phase 1
Completed
18 enrolled